comparemela.com

Latest Breaking News On - Pharmather holdings - Page 12 : comparemela.com

Revive Therapeutics Provides Update of Psilocybin

IRB approval to initiate Phase 2 study for methamphetamine abuse disorders Advancing psilocybin oral thin film, microneedle patch and biosynthesis.

Antigua and barbudaUnited statesPaul hutsonMichael frankGavin williamsChristopher nicholasSchool of medicineTherapeutics ltdSchool of pharmacyUniversity of wisconsinPublic healthPsilocybin international researchUniversity of health sciences antiguaPharmather holdings ltdPsilocin pharma corpNeither the canadian securities exchange

PharmaTher Announces FDA Approval of Investigational New Drug (IND) Application for Ketamine to Treat ALS

TORONTO, Jan. 12, 2022 (GLOBE NEWSWIRE) PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a company focused on the…

United statesRichard barohnLou gehrigFabio chianelliUniversity of kansasHuman servicesCompany or pharmatherRisk factors in companyDrug administrationUniversity of missouriHealth affairsPharmather holdings ltdNeither the canadian securities exchangeNextgen precision healthPostmedia network incDepartment of health

Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs

Revive Therapeutics is pleased to provide an update on the Company’s psilocybin pharmaceutical development programs.

Paul hutsonGavin williamsChristopher nicholasUniversity of wisconsinPublic healthPharmather holdings ltdSchool of medicineTherapeutics ltdSchool of pharmacyCarolina state universityMethamphetamine useInstitutional review boardPharmather holdingsNorth carolina state university

Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Antigua and barbudaUnited statesPaul hutsonMichael frankGavin williamsChristopher nicholasSchool of medicineTherapeutics ltdSchool of pharmacyPublic healthPsilocybin international researchUniversity of wisconsinUniversity of health sciences antiguaPharmather holdings ltdPsilocin pharma corpCarolina state university

PharmaTher Announces FDA Approval of Investigational New

TORONTO, Jan. 12, 2022 (GLOBE NEWSWIRE) PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a company focused on the.

United statesRichard barohnLou gehrigFabio chianelliUniversity of kansasHuman servicesCompany or pharmatherDrug administrationUniversity of missouriHealth affairsPharmather holdings ltdNextgen precision healthNeither the canadian securities exchangeDepartment of healthMu health careRegulation services provider

vimarsana © 2020. All Rights Reserved.